Press Release: AI-Powered Diagnostics Platform PMcardio Now Accessible to Healthcare Professionals in 15 New European Markets
PMcardio, a leading force in AI-powered diagnostics for cardiovascular diseases, announces expansion into 15 additional European markets with the launch of its newest version.
Dr. Yassir Javaid, Award-Winning Cardiologist, Strengthens UK Clinical Board for PMcardio
We are happy to share that Dr. Yassir Javaid, a distinguished General Practitioner specialising in Cardiology, has joined our UK Clinical Board. Recognised for his dynamic integration of primary care experience and cardiology expertise, Dr. Javaid brings a valuable and strategic perspective to our team.
Powerful Medical Wins the Venture Capital Deal of the Year Award!
We are thrilled to announce that Powerful Medical has been awarded the esteemed title of Venture Capital Deal of the Year at the CVCA & SLOVCA Awards competition. This recognition is a testament to our team’s dedication and the significant strides we’ve made in the past year.
Powerful Medical in the Heart magazine, the official journal of the British Cardiovascular Society
Powerful Medical has been featured in the latest issue of Heart Magazine, a global, peer-reviewed journal that keeps cardiologists informed of the latest breakthroughs in cardiovascular disease.
We have officially launched PMcardio!
We are excited to announce that today we are officially launching PMcardio! After years of development, we are beyond happy to finally deliver our AI-powered medical application into your hands. You can now download PMcardio from the Apple app store or the Google Play store.
Powerful Medical’s 2022: A year in review
For us at Powerful Medical, 2022 was a year of maturing and growth. We went through many changes, both as a business, as well as a team.
Powerful Medical raises 6.2 million EUR in Seed funding
We’re proud to announce that we’ve just raised €6.2 million in Seed funding round, marking a significant milestone in Powerful Medical’s journey of revolutionizing cardiovascular care.
Heart Failure Prediction: PM-Aalst heart failure mortality prediction system published in the ESC
We developed a transparent machine learning model predicting mortality in heart failure patients and our peer-reviewed study was just published in the ESC Heart Failure journal.
We have successfully received the CE-mark for PMcardio under the EU Medical Device Regulation!
Thanks to our system-wide compliance, PMcardio successfully attained third-party certification as a Class (II)b medical device through the notified body, TÜV SÜD Product Service GmbH.
Powerful Medical launches ‘PMcardio-1’ – a clinical trial under the new EU MDR
Powerful Medical launches the historically first medical device clinical trial under the new EU Medical Device Regulation in Slovakia in cooperation with two of Slovakia’s largest private health insurers.
